Induced pluripotent stem cell-Derived cells (iPSC-Derived cells)

Induced pluripotent stem cell-derived cells (iPSC-derived cells) are specialized somatic cells generated through lineage-specific differentiation of iPSCs. These cells encompass a broad range of human cell types, including neurons, cardiomyocytes, hepatocytes, blood cells, and pancreatic β cells, which closely mimic their in vivo counterparts in structure and function. By replicating key aspects of human development and disease pathology in vitro, iPSC-derived cells provide a unique platform for both basic and translational applications. Their ability to retain the genetic background of the donor makes them particularly valuable for modeling patient-specific diseases and assessing individualized therapeutic responses. This capability is transforming the fields of precision medicine, cell-based therapies, and regenerative medicine. Functionally, iPSC-derived cells play essential roles in a wide range of physiological and pathological processes, including cardiac physiology, immune modulation, tissue repair, neurodevelopment, and metabolic regulation. Their capacity for scalable production, unlimited proliferative capacity, multipotent differentiation potential, and retention of patient-specific genetic backgrounds, has made them indispensable tools in disease modeling, high-throughput drug screening, toxicity testing, and development of next-generation regenerative therapies. They are receiving increasing attention in both basic research and clinical translation. To support diverse research and therapeutic applications, AcceGen offers a comprehensive portfolio of human iPSC-derived cell products. Our product line includes high-quality, well-characterized neurons, cardiomyocytes, hepatocytes, pancreatic β cells, and hematopoietic cells, each rigorously validated for identity, purity, and functionality. These cells are widely used in pharmaceutical research, academic studies, and preclinical investigations. By accurately mimicking human in vivo physiological conditions in vitro, AcceGen’s iPSC-derived cell products accelerate the discovery of disease mechanisms, facilitate drug development, and enable the creation of personalized treatment strategies. Explore our product catalog to find the ideal iPSC-derived cell type for your research or therapeutic development needs.